furosemide and 19-hydroxy-4-androstene-3,17-dione

furosemide has been researched along with 19-hydroxy-4-androstene-3,17-dione in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mercado-Asis, LB; Miura, K; Miyazaki, S; Morita, H; Mune, T; Murayama, M; Yamakita, N; Yasuda, K1
Ohsawa, N; Sekihara, H1
Miura, K; Miyazaki, S; Morita, H; Mune, T; Yamakita, N; Yasuda, K1

Trials

1 trial(s) available for furosemide and 19-hydroxy-4-androstene-3,17-dione

ArticleYear
Low plasma 19-hydroxyandrostenedione levels in patients with aldosterone-producing adenoma.
    Endocrine journal, 1993, Volume: 40, Issue:1

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Androstenedione; Blood Pressure; Dexamethasone; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Radioimmunoassay

1993

Other Studies

2 other study(ies) available for furosemide and 19-hydroxy-4-androstene-3,17-dione

ArticleYear
Secretory regulation of 19-hydroxyandrostenedione in normal man.
    Endocrinologia japonica, 1992, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aldosterone; Androstenedione; Captopril; Cosyntropin; Dexamethasone; Female; Furosemide; Humans; Hydrocortisone; Male; Middle Aged; Pituitary-Adrenal System; Radioimmunoassay; Renin; Renin-Angiotensin System

1992
19-hydroxyandrostenedione, a new amplifier of the action of aldosterone, in low renin essential hypertension.
    Japanese journal of medicine, 1982, Volume: 21, Issue:2

    Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Cushing Syndrome; Female; Furosemide; Humans; Hypertension; Male

1982